Page 4 - Ping Cao News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ping cao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ping Cao Today - Breaking & Trending Today
BridGene Biosciences to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
BridGene Biosciences to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
A Queensland man who dissolved his wife s body in a wheelie-bin of acid after murdering her is applying for parole after serving less than 10 years in jail. ....
BridGene Biosciences Announces $12 Million Series A Financing to Advance the Company s Proprietary Chemoproteomic Platform and Pipeline of Oncology Programs News provided by Share this article Share this article SUNNYVALE, Calif., May 5, 2021 /PRNewswire/ BridGene Biosciences, Inc., a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules for high value, yet traditionally undruggable targets, announced today it has raised $12 million in a Series A private financing round led by Wedo Venture Partners with additional participation by Kaitai Capital and Takeda Ventures, alongside existing investor Pangu Venture. BridGene plans to use proceeds from the Series A financing to expand the company s proprietary covalent library to discover small-molecule ligands for a broader range of targets, advance existing oncology programs and enhance operations. ....
Published: May 05, 2021 By Mark Terry There’s money on the move and venture capital firms launch several biotech companies with hefty Series A financing rounds. Here’s a look. Esker Launches with $70 Million Series A San Francisco-based Esker Therapeutics, a Foresite Labs-incubated company, launched with a $70 million Series A financing. The round was led by Foresite Capital. The company focuses on autoimmune diseases and so-called precision therapies that target patients most likely to benefit from them. The company’s precision analytics platform is powered by Foresite Labs. The technology platform is made up of high-quality curated genetic, clinical and medical record data, a systems immunology approach for prospective data collections and tools for building patient registries. Its lead pipeline product is ESK-001, a highly selective TYK2 inhibitor with greater selectivity for TYK2 over JAK1, initially in development for psoriasis. It is ....